Trial Profile
Efficacy of house-dust-mite immunotherapy in adult patients with asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs House dust mite allergy immunotherapy injection ALK Abello (Primary)
- Indications Asthma
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 05 Nov 2010 New trial record.